MO‐D‐I‐609‐08: Validation of PET Hypoxia Tracers by Autoradiography and Fluorescent Microscopy

Andrei Pugachev, F. Claus, X. Sun, S. Ruan, S. Cai, J. Koziorowsky, R. Finn, J. O”donoghue, C. Ling, J. Humm

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To develop a method for PET hypoxia tracer validation based on statistical analysis of the spatial correspondence between the intratumoral distributions of tracer uptake (assessed by digital autoradiography) and pimonidazole, an independent marker of hypoxia (assessed by immunofluorescent microscopy). The utility of the method was demonstrated by applying it to three PET hypoxia tracers, IAZGP, FMISO and Cu‐ATSM. Method and Materials: Eight rats bearing R3327‐AT tumors were divided into four groups of two animals each. Group♯1 was injected with 18F‐FMISO and sacrificed 2hr later. Group♯2 was injected with 124I‐IAZGP and sacrificed 3hr later. Groups♯3 and ♯4 were injected with 64Cu‐ATSM and sacrificed, respectively, 24hr or 1hr later. Pimonidazole was administered to all animals 2hr before sacrifice. Tumors were excised, frozen and sectioned. Digital autoradiograms of the tracer distribution were obtained from selected sections and co‐registered with images of pimonidazole‐associated immunofluorescence derived from adjacent sections. The statistical analysis of association between PET tracer uptake and pimonidazole immunofluorescent staining intensity was then performed on a pixel‐by‐pixel basis. Results: For rats from group♯1 correlation coefficients between pimonidazole‐associated immunofluorescent staining intensity and 18F‐FMISO uptake were 0.84 and 0.75. For group♯2 rats correlations between pimonidazole and 124I‐IAZGP were 0.85 and 0.77. For group♯3 (64Cu‐ATSM administered 24hr prior to sacrifice), the correlations with pimonidazole were 0.61 and 0.64. However, for group♯4 (64Cu‐ATSM administered 1hr prior to sacrifice), the correlation coefficients were −0.76 and −0.77, demonstrating that in this tumor model 64Cu‐ATSM uptake was not indicative of hypoxia at early times post injection. Conclusion: The proposed method enables evaluation of the degree of spatial correspondence between distributions of a PET tracer and alternative markers (either endogenous or exogenous) or tracers of the biological process under study. This method can be used for the in‐vivo validation of any nuclear medicine tracer.

Original languageEnglish (US)
Number of pages1
JournalMedical Physics
Volume32
Issue number6
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Autoradiography
Microscopy
Staining and Labeling
Biological Phenomena
Neoplasms
Spatial Analysis
Nuclear Medicine
Fluorescent Antibody Technique
pimonidazole
Hypoxia
Injections

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

MO‐D‐I‐609‐08 : Validation of PET Hypoxia Tracers by Autoradiography and Fluorescent Microscopy. / Pugachev, Andrei; Claus, F.; Sun, X.; Ruan, S.; Cai, S.; Koziorowsky, J.; Finn, R.; O”donoghue, J.; Ling, C.; Humm, J.

In: Medical Physics, Vol. 32, No. 6, 01.01.2005.

Research output: Contribution to journalArticle

Pugachev, A, Claus, F, Sun, X, Ruan, S, Cai, S, Koziorowsky, J, Finn, R, O”donoghue, J, Ling, C & Humm, J 2005, 'MO‐D‐I‐609‐08: Validation of PET Hypoxia Tracers by Autoradiography and Fluorescent Microscopy', Medical Physics, vol. 32, no. 6. https://doi.org/10.1118/1.1998244
Pugachev, Andrei ; Claus, F. ; Sun, X. ; Ruan, S. ; Cai, S. ; Koziorowsky, J. ; Finn, R. ; O”donoghue, J. ; Ling, C. ; Humm, J. / MO‐D‐I‐609‐08 : Validation of PET Hypoxia Tracers by Autoradiography and Fluorescent Microscopy. In: Medical Physics. 2005 ; Vol. 32, No. 6.
@article{a8b6c34923fe4212b9fb7b4dae74e7db,
title = "MO‐D‐I‐609‐08: Validation of PET Hypoxia Tracers by Autoradiography and Fluorescent Microscopy",
abstract = "Purpose: To develop a method for PET hypoxia tracer validation based on statistical analysis of the spatial correspondence between the intratumoral distributions of tracer uptake (assessed by digital autoradiography) and pimonidazole, an independent marker of hypoxia (assessed by immunofluorescent microscopy). The utility of the method was demonstrated by applying it to three PET hypoxia tracers, IAZGP, FMISO and Cu‐ATSM. Method and Materials: Eight rats bearing R3327‐AT tumors were divided into four groups of two animals each. Group♯1 was injected with 18F‐FMISO and sacrificed 2hr later. Group♯2 was injected with 124I‐IAZGP and sacrificed 3hr later. Groups♯3 and ♯4 were injected with 64Cu‐ATSM and sacrificed, respectively, 24hr or 1hr later. Pimonidazole was administered to all animals 2hr before sacrifice. Tumors were excised, frozen and sectioned. Digital autoradiograms of the tracer distribution were obtained from selected sections and co‐registered with images of pimonidazole‐associated immunofluorescence derived from adjacent sections. The statistical analysis of association between PET tracer uptake and pimonidazole immunofluorescent staining intensity was then performed on a pixel‐by‐pixel basis. Results: For rats from group♯1 correlation coefficients between pimonidazole‐associated immunofluorescent staining intensity and 18F‐FMISO uptake were 0.84 and 0.75. For group♯2 rats correlations between pimonidazole and 124I‐IAZGP were 0.85 and 0.77. For group♯3 (64Cu‐ATSM administered 24hr prior to sacrifice), the correlations with pimonidazole were 0.61 and 0.64. However, for group♯4 (64Cu‐ATSM administered 1hr prior to sacrifice), the correlation coefficients were −0.76 and −0.77, demonstrating that in this tumor model 64Cu‐ATSM uptake was not indicative of hypoxia at early times post injection. Conclusion: The proposed method enables evaluation of the degree of spatial correspondence between distributions of a PET tracer and alternative markers (either endogenous or exogenous) or tracers of the biological process under study. This method can be used for the in‐vivo validation of any nuclear medicine tracer.",
author = "Andrei Pugachev and F. Claus and X. Sun and S. Ruan and S. Cai and J. Koziorowsky and R. Finn and J. O”donoghue and C. Ling and J. Humm",
year = "2005",
month = "1",
day = "1",
doi = "10.1118/1.1998244",
language = "English (US)",
volume = "32",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - MO‐D‐I‐609‐08

T2 - Validation of PET Hypoxia Tracers by Autoradiography and Fluorescent Microscopy

AU - Pugachev, Andrei

AU - Claus, F.

AU - Sun, X.

AU - Ruan, S.

AU - Cai, S.

AU - Koziorowsky, J.

AU - Finn, R.

AU - O”donoghue, J.

AU - Ling, C.

AU - Humm, J.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Purpose: To develop a method for PET hypoxia tracer validation based on statistical analysis of the spatial correspondence between the intratumoral distributions of tracer uptake (assessed by digital autoradiography) and pimonidazole, an independent marker of hypoxia (assessed by immunofluorescent microscopy). The utility of the method was demonstrated by applying it to three PET hypoxia tracers, IAZGP, FMISO and Cu‐ATSM. Method and Materials: Eight rats bearing R3327‐AT tumors were divided into four groups of two animals each. Group♯1 was injected with 18F‐FMISO and sacrificed 2hr later. Group♯2 was injected with 124I‐IAZGP and sacrificed 3hr later. Groups♯3 and ♯4 were injected with 64Cu‐ATSM and sacrificed, respectively, 24hr or 1hr later. Pimonidazole was administered to all animals 2hr before sacrifice. Tumors were excised, frozen and sectioned. Digital autoradiograms of the tracer distribution were obtained from selected sections and co‐registered with images of pimonidazole‐associated immunofluorescence derived from adjacent sections. The statistical analysis of association between PET tracer uptake and pimonidazole immunofluorescent staining intensity was then performed on a pixel‐by‐pixel basis. Results: For rats from group♯1 correlation coefficients between pimonidazole‐associated immunofluorescent staining intensity and 18F‐FMISO uptake were 0.84 and 0.75. For group♯2 rats correlations between pimonidazole and 124I‐IAZGP were 0.85 and 0.77. For group♯3 (64Cu‐ATSM administered 24hr prior to sacrifice), the correlations with pimonidazole were 0.61 and 0.64. However, for group♯4 (64Cu‐ATSM administered 1hr prior to sacrifice), the correlation coefficients were −0.76 and −0.77, demonstrating that in this tumor model 64Cu‐ATSM uptake was not indicative of hypoxia at early times post injection. Conclusion: The proposed method enables evaluation of the degree of spatial correspondence between distributions of a PET tracer and alternative markers (either endogenous or exogenous) or tracers of the biological process under study. This method can be used for the in‐vivo validation of any nuclear medicine tracer.

AB - Purpose: To develop a method for PET hypoxia tracer validation based on statistical analysis of the spatial correspondence between the intratumoral distributions of tracer uptake (assessed by digital autoradiography) and pimonidazole, an independent marker of hypoxia (assessed by immunofluorescent microscopy). The utility of the method was demonstrated by applying it to three PET hypoxia tracers, IAZGP, FMISO and Cu‐ATSM. Method and Materials: Eight rats bearing R3327‐AT tumors were divided into four groups of two animals each. Group♯1 was injected with 18F‐FMISO and sacrificed 2hr later. Group♯2 was injected with 124I‐IAZGP and sacrificed 3hr later. Groups♯3 and ♯4 were injected with 64Cu‐ATSM and sacrificed, respectively, 24hr or 1hr later. Pimonidazole was administered to all animals 2hr before sacrifice. Tumors were excised, frozen and sectioned. Digital autoradiograms of the tracer distribution were obtained from selected sections and co‐registered with images of pimonidazole‐associated immunofluorescence derived from adjacent sections. The statistical analysis of association between PET tracer uptake and pimonidazole immunofluorescent staining intensity was then performed on a pixel‐by‐pixel basis. Results: For rats from group♯1 correlation coefficients between pimonidazole‐associated immunofluorescent staining intensity and 18F‐FMISO uptake were 0.84 and 0.75. For group♯2 rats correlations between pimonidazole and 124I‐IAZGP were 0.85 and 0.77. For group♯3 (64Cu‐ATSM administered 24hr prior to sacrifice), the correlations with pimonidazole were 0.61 and 0.64. However, for group♯4 (64Cu‐ATSM administered 1hr prior to sacrifice), the correlation coefficients were −0.76 and −0.77, demonstrating that in this tumor model 64Cu‐ATSM uptake was not indicative of hypoxia at early times post injection. Conclusion: The proposed method enables evaluation of the degree of spatial correspondence between distributions of a PET tracer and alternative markers (either endogenous or exogenous) or tracers of the biological process under study. This method can be used for the in‐vivo validation of any nuclear medicine tracer.

UR - http://www.scopus.com/inward/record.url?scp=52449098759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52449098759&partnerID=8YFLogxK

U2 - 10.1118/1.1998244

DO - 10.1118/1.1998244

M3 - Article

AN - SCOPUS:52449098759

VL - 32

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -